Single vs. Double Drain in Modified Radical Mastectomy
Study Details
Study Description
Brief Summary
Seroma is a common complication following modified radical mastectomy(MRM). Closed drainage is used routinely to reduce incidence of seroma. Usually two drains are used in patients who underwent MRM to reduce post operative seroma. It is often associated with significant patient discomfort and prolonged fluid drainage.
The aim of this study is to evaluate effect of number of drains on seroma formation rate, postoperative pain and hospital stay during the immediate postoperative period after mastectomy for breast cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Modified Radical mastectomy is commonly performed procedure for carcinoma breast. After surgery two drains are placed, one in axilla and one beneath the flap. The use of two drains is associated with significant post operative discomfort and pain. On the other hand two drains have not been proven to decrease post operative seroma formation.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Single drain in modified radical mastectomy Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain |
Device: Drain
Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain
|
Active Comparator: Double drain in modified radical mastectomy Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain |
Device: Drain
Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain
|
Outcome Measures
Primary Outcome Measures
- seroma formation [30 days post surgery]
fluid collection beneath the flap sufficient to cause patient discomfort and pain
Secondary Outcome Measures
- Duration of hospital stay,, [30 days after surgery]
- wound infection [30 days after surgery]
as described by center of disease control (CDC) criteria
- postoperative pain [30 days after surgery]
measured on visual analogue scale (1 to 10) in first 24 hours after surgery.
- hematoma [30 days after surgery]
blood collection under the flap
- flap necrosis [30 days after surgery]
flap discoloration due to compromised blood supply of flap
Eligibility Criteria
Criteria
Inclusion Criteria:
- All female patients underwent MRM for biopsy proven carcinoma breast
Exclusion Criteria:
-
Immediate reconstruction
-
Patient refusal to participate in study
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Memon Medical Institute
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ERC:02